Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29214129 | 1.00 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL1417103 | 0.73 | SLC7A5 (0.50) | SLC7A5SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL9425473 | 0.72 | — | — | |
| SCHEMBL9425465 | 0.72 | — | — | |
| SCHEMBL15049514 | 0.72 | — | — | |
| SCHEMBL4220900 | 0.72 | — | — | |
| SCHEMBL15049515 | 0.72 | — | — | |
| SCHEMBL24520194 | 0.70 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL3744073 | 0.70 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3 | |
| Bromide SCHEMBL5466773 | 0.70 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112585116-B | Synthesis of (2S, 3R, 4R) -4, 5-dihydroxyisoleucine and derivatives thereof | 海德堡医药研究有限责任公司 | 2024-05-14 | — | — | CN | claimed |
| US-11584708-B2 | Synthesis of (2S,3R,4R)-4,5-dihydroxyisoleucine and derivatives | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2023-02-21 | — | — | US | claimed |
| CN-112585116-B | Synthesis of (2S, 3R, 4R) -4, 5-dihydroxyisoleucine and derivatives thereof | 海德堡医药研究有限责任公司 | 2024-05-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584708-B2 | Synthesis of (2S,3R,4R)-4,5-dihydroxyisoleucine and derivatives | AGL, GLUL, DAO | SLC7A5 183/4885SLC1A2 340/4885SLC1A1 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.